Home » Stocks » PEN

Penumbra, Inc. (PEN)

Stock Price: $266.40 USD -0.74 (-0.28%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 9.72B
Revenue (ttm) 592.29M
Net Income (ttm) -5.29M
Shares Out 36.46M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE 588.24
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $266.40
Previous Close $267.14
Change ($) -0.74
Change (%) -0.28%
Day's Open 268.48
Day's Range 265.22 - 271.43
Day's Volume 154,140
52-Week Range 163.49 - 314.22

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ALAMEDA, Calif., July 12, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market close ...

1 week ago - PRNewsWire

Penumbra (PEN) to initiate commercialization of RED 62 Reperfusion Catheter post FDA clearance.

1 month ago - Zacks Investment Research

ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #mechanicalthrombectomy--Penumbra has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED™ 62 Reperfusion ...

1 month ago - Business Wire

ALAMEDA, Calif., May 18, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 41st Annual Growth Stock Virtual Conference...

2 months ago - PRNewsWire

Penumbra (PEN) delivered earnings and revenue surprises of 145.45% and 10.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Penumbra (NYSE:PEN) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 0.00% over the past year to $0.27, which beat the esti...

2 months ago - Benzinga

ALAMEDA, Calif., May 4, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 3...

2 months ago - PRNewsWire

If you like good news and support from experts, this one's for you.

Other stocks mentioned: IHI
2 months ago - The Motley Fool

ALAMEDA, Calif., April 27, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference on ...

2 months ago - PRNewsWire

Growth across vascular thrombectomy and embolization products is expected to have contributed to Penumbra's (PEN) Q1 performance.

2 months ago - Zacks Investment Research

Bull of the Day: Penumbra (PEN)

3 months ago - Zacks Investment Research

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

Other stocks mentioned: ABT, AMEH, HSIC, NDRA, NTUS, OMI
3 months ago - Zacks Investment Research

ALAMEDA, Calif., April 13, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2021 after market close ...

3 months ago - PRNewsWire

Netflix and Facebook are among the top stocks for April. Q.ai's Artificial Intelligence has also dug up top tech stocks, top consumer stocks, top quality value stocks, and top growth stocks.

Other stocks mentioned: ABBV, ADBE, FB, GM, KLAC, NFLX, NKE ...
3 months ago - Forbes

Top Picks for Investors Interested in the Shipping and Medical Space.

Other stocks mentioned: DAC
3 months ago - Zacks Investment Research

Is (PEN) Outperforming Other Medical Stocks This Year?

4 months ago - Zacks Investment Research

Penumbra's (PEN) INDIGO System Lightning 7 assists physicians in easing arterial thrombus removal with single-session results.

4 months ago - Zacks Investment Research

ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #mechanicalthrombectomy--Indigo® System CAT™7 Aspiration Catheter with Lightning™ Intelligent Aspiration powered by Penumbra ENGINE® is now commercially availab...

4 months ago - Business Wire

New York, New York--(Newsfile Corp. - March 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...

4 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...

4 months ago - Newsfile Corp

NEW ORLEANS, March 15, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the f...

Other stocks mentioned: CLOV, IRTC, NTNX
4 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that th...

4 months ago - Newsfile Corp

Investors with losses are encouraged to contact the firm before March 16, 2021 ; click  here  to submit trade information ​

4 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 15, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pe...

4 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 15, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 ...

4 months ago - Newsfile Corp

Low-beta stocks may be able to help sail through the choppy market conditions.

Other stocks mentioned: NTUS, OMI, RCKY, RGR
4 months ago - Zacks Investment Research

RADNOR, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Cou...

4 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 13, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 ...

4 months ago - Newsfile Corp

Radnor, Pennsylvania--(Newsfile Corp. - March 13, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Penumbr...

4 months ago - Newsfile Corp

RADNOR, Pa.--(BUSINESS WIRE)---- $PEN #classaction--Kessler Topaz Meltzer & Check, LLP Announces 4 Day Deadline Reminder in Securities Class Action Lawsuit Filed Against Penumbra, Inc.

4 months ago - Business Wire

New York, New York--(Newsfile Corp. - March 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...

4 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $PEN #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Penumbra, Inc. (PEN)

4 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - March 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...

4 months ago - Newsfile Corp

RADNOR, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Cou...

4 months ago - GlobeNewsWire

New Orleans, Louisiana--(Newsfile Corp. - March 11, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un...

4 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - March 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. (NY...

4 months ago - Newsfile Corp

SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of Penumbra, Inc. ("Penumbra" or the "Company") (NYSE: PEN...

4 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 11, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that th...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...

4 months ago - Newsfile Corp

RADNOR, Pa., March 10, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. (NYSE:  PEN) (...

4 months ago - PRNewsWire

NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...

4 months ago - GlobeNewsWire

Bull of the Day: Penumbra (PEN)

4 months ago - Zacks Investment Research

New York, New York--(Newsfile Corp. - March 9, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that the...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Penu...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 9, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 a...

4 months ago - Newsfile Corp

NEW YORK, March 8, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15,...

4 months ago - PRNewsWire

Radnor, Pennsylvania--(Newsfile Corp. - March 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc ("...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that the...

4 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - March 8, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...

4 months ago - Newsfile Corp

About PEN

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovas... [Read more...]

Industry
Medical Devices
IPO Date
Sep 18, 2015
CEO
Adam Elsesser
Employees
3,300
Stock Exchange
NYSE
Ticker Symbol
PEN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Penumbra stock is "Buy." The 12-month stock price forecast is 315.40, which is an increase of 18.39% from the latest price.

Price Target
$315.40
(18.39% upside)
Analyst Consensus: Buy